Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ALXO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Jason Lettmann CHIEF EXECUTIVE OFFICER, Director | ALXO ALX Oncology Holdings Inc. | Sale | 2,230 | $1.93 | $4,304 Sale | Form 4 ↗ |
| Aug 17, 2026 | Shelly Wong SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 573 | $1.93 | $1,106 Sale | Form 4 ↗ |
| Jul 1, 2026 | Shelly Wong SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 1,404 | $2.04 | $2,864 Sale | Form 4 ↗ |
| Mar 19, 2026 | Jason Lettmann CHIEF EXECUTIVE OFFICER, Director | ALXO ALX Oncology Holdings Inc. | Sale | 12,311 | $2.17 | $26.7K Sale | Form 4 ↗ |
| Mar 19, 2026 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 903 | $2.17 | $1,960 Sale | Form 4 ↗ |
| Feb 18, 2026 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 565 | $2.27 | $1,283 Sale | Form 4 ↗ |
| Feb 2, 2026 | Corey S. Goodman Director, 10% owner | ALXO ALX Oncology Holdings Inc. | Buy | 3.18M | $1.57 | $5.0M Buy | Form 4 ↗ |
| Jan 6, 2026 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 3,925 | $1.11 | $4,357 Sale | Form 4 ↗ |
| Sep 17, 2025 | Jason Lettmann CHIEF EXECUTIVE OFFICER, Director | ALXO ALX Oncology Holdings Inc. | Buy | 71,163 | $1.08 | $76.9K Buy | Form 4 ↗ |
| Sep 16, 2025 | Jason Lettmann CHIEF EXECUTIVE OFFICER, Director | ALXO ALX Oncology Holdings Inc. | Buy | 21,070 | $1.07 | $22.5K Buy | Form 4 ↗ |
| Aug 18, 2025 | Harish Shantharam Chief Financial Officer | ALXO ALX Oncology Holdings Inc. | Buy | 75,000 | $0.78 | $58.5K Buy | Form 4 ↗ |
| Aug 15, 2025 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 611 | $0.64 | $391 Sale | Form 4 ↗ |
| Aug 15, 2025 | Jason Lettmann CHIEF EXECUTIVE OFFICER, Director | ALXO ALX Oncology Holdings Inc. | Sale | 2,382 | $0.64 | $1,524 Sale | Form 4 ↗ |
| Jul 7, 2025 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 2,011 | $0.45 | $905 Sale | Form 4 ↗ |
| Jun 30, 2025 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 1,532 | $0.43 | $659 Sale | Form 4 ↗ |
| Feb 19, 2025 | Shelly Pinto SVP, FINANCE AND CAO | ALXO ALX Oncology Holdings Inc. | Sale | 550 | $1.15 | $633 Sale | Form 4 ↗ |
| Feb 19, 2025 | Jaume Pons PRESIDENT & CSO | ALXO ALX Oncology Holdings Inc. | Sale | 1,326 | $1.15 | $1,525 Sale | Form 4 ↗ |
| Feb 19, 2025 | Jason Lettmann CHIEF EXECUTIVE OFFICER, Director | ALXO ALX Oncology Holdings Inc. | Sale | 2,159 | $1.15 | $2,483 Sale | Form 4 ↗ |
| Jan 6, 2025 | Shelly Pinto Interim CFO | ALXO ALX Oncology Holdings Inc. | Sale | 2,221 | $1.80 | $3,998 Sale | Form 4 ↗ |
| Dec 30, 2024 | Shelly Pinto Interim CFO | ALXO ALX Oncology Holdings Inc. | Sale | 1,426 | $1.58 | $2,253 Sale | Form 4 ↗ |
| Dec 30, 2024 | Jaume Pons PRESIDENT & CSO | ALXO ALX Oncology Holdings Inc. | Sale | 10,796 | $1.58 | $17.1K Sale | Form 4 ↗ |
| Dec 2, 2024 | Rekha Hemrajani Director | ALXO ALX Oncology Holdings Inc. | Buy | 30,000 | $1.55 | $46.5K Buy | Form 4 ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances